FDC launches Favipiravir oral suspension to treat COVID-19 in India

In order to combat COVID-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our efforts in making the process of COVID-19 treatment hassle-free," FDC Business Development & Commercial Excellence General Manager Mayank Tikkha said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Vtaled
via IFTTT

0 comments:

Post a Comment